Experiences of living with trimethyalminuria, a metabolic disorder which leads to breath and body odour
Published in Public Health
What is trimethylaminuria?
Trimethylaminuria is a rare disorder characterised by impaired metabolism of trimethylamine, a volatile amine which has a strong odour resembling rotting fish. Trimethylamine leaves the body as a gas through the breath, sweat and other bodily secretions, giving individuals an unpleasant and distinctive body odour. There are both acquired and inherited forms of the condition which arise from disturbance of a metabolic axis including the gut microbiome and a hepatic enzyme FMO3.
Why did we do this study?
Individuals with trimethylaminuria often appear physically healthy. However, we now understand the disorder in its biopsychosocial context and know that social isolation and stress eventually impact negatively on physical health. Until now there has been only anecdotal and small study evidence of the psychological and social consequences of living with trimethylaminuria. It is estimated that 1 in 40,000 people may have the inherited form of the disorder, with many more having a mixed or acquired version of the disorder. There is currently no guidance on the diagnosis and management of trimethylaminuria in the UK.
What did we find?
Our findings show that trimethylaminuria can cause immense hardship and distress. Quantitative data showed that 90% of respondents felt disadvantaged in the workplace, and 90% felt disadvantaged in their social lives. Interestingly, only 28% and 21% of respondents felt disadvantaged in school or university respectively. 90% of respondents had suffered bullying, harassment, and ostracism in the workplace. Another key theme which emerged was difficulty and delay in gaining a diagnosis or diagnostic test. Only 73% of respondents had been offered a diagnostic urine test for trimethylaminuria, and only 22% had been offered a genetic test. Qualitative responses highlighted a concerning lack of understanding and compassion from clinicians, and that people with trimethylaminuria generally felt unsupported by the health service.
What next?
Respondents had an opportunity to suggest changes which would improve quality of life. Many suggested that a greater understanding of trimethylaminuria and its consequences by their healthcare providers, authority figures and the public. Respondents wished that there were protections in place to stop them from being discriminated against, others thought that because of the unpredictable nature of symptoms more flexibility in work and study would be beneficial. These suggestions could be facilitated by classifying trimethylaminuria as a disability under the Equality Act 2010. This would protect individuals from discrimination and allow reasonable adjustments by employers and educators.
There are currently no definitive treatments for trimethylaminuria, but trimethylamine excretion can sometimes be lessened with a restrictive diet, riboflavin supplements, and probiotics. Short-term antibiotic therapy has been used in some individuals, however this does not cause long-term symptom relief. Importantly, there is no clinical guidance for the management of trimethylaminuria. Publication of such evidence-based advice would be hugely beneficial for clinicians and patients alike.
Follow the Topic
-
BMC Public Health
An open access, peer-reviewed journal that considers articles on the epidemiology of disease and the understanding of all aspects of public health.
Related Collections
With Collections, you can get published faster and increase your visibility.
Endocrine disruption as a public health issue
BMC Public Health invites submissions to our new Collection, Endocrine disruption as a public health issue. Endocrine disruption has emerged as a growing public health challenge, characterized by the interference of certain chemicals with the normal functioning of the endocrine system. Endocrine disrupting chemicals (EDCs) can mimic, block, or alter hormone signaling, leading to a range of adverse health outcomes. Common sources of EDC exposure include everyday products such as plastics, pesticides, and personal care items, all of which can release substances like bisphenols and phthalates into the environment and human body. Understanding the links between exposure to EDCs and eventual health outcomes is vital for assessing their implications for population health.
We welcome submissions that delve into various aspects of endocrine disruption. Key topics of interest include, but are not limited to:
Role of EDCs in metabolic, endocrine and immune-related disorders
Effect of EDCs in consumer products including personal care products
The links between EDC exposure and male and female reproductive health problems
The links between EDC exposure and certain cancers
Insights into the long-term consequences of early-life EDC exposure and transgenerational effects
Methodological advances in assessing the health impacts of EDC mixtures and cumulative exposures
Development and application of statistical approaches to better estimate the health effects of chronic and/or concurrent exposure
Validating models of cumulative exposure with measurement of combinations of EDCs in human tissues
Individual- and policy-level interventions to address health impacts of EDC exposures
The search for substitutes lacking endocrine disrupting properties
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Aug 26, 2026
Life-course approaches to chronic disease prevention
BMC Public Health is calling for submissions to our Collection on Life‑course approaches to chronic disease prevention. This Collection highlights research that examines how health trajectories are shaped from early development through older adulthood, and how targeted interventions at key stages of life can reduce the burden of chronic diseases.
We welcome studies that explore behavioral, social, and environmental influences across the life-course, as well as research that evaluates policies and programs designed to promote long‑term health. Topics of interest include, but are not limited to:
- Long-term effects of early-life interventions across multiple domains
- The role of adverse childhood experiences and developmental trauma throughout the life course
- Lifelong behavioral trajectories and their cumulative impact
- Innovative methodologies in life-course epidemiology
- Evaluation of the effectiveness of life-course interventions in preventing chronic diseases
- Implications of life-course approaches for policy development and health promotion strategies
By bringing together diverse perspectives, we aspire to inspire actionable insights that can guide effective public health strategies and improve health equity for all.
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Feb 20, 2027
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in